מן הרשת 21.10.202513:19 Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies The review evaluates existing evidence for the use of these therapies in pediatric populations, with an emphasis on both existing clinical trials and real-world data that supports their use Neurotherapeutics
מן הרשת 21.10.202513:18 Advancing multiple sclerosis management in older adults we present the outcomes of an International Advisory Committee on Clinical Trials (IACCT) in MS workshop on ageing and MS; we review the current status of the field and identify knowledge gaps, and provide recommendations to advance the areas of unmet need nature reviews neurology
מן הרשת 21.10.202513:17 Re-defining progression in multiple sclerosis The purpose of this article is to provide an overview of progression in multiple sclerosis (MS), including definitions, pathological mechanisms, and evidence that progressive biology begins early in the disease course Current Opinion in Neurology
מן הרשת 21.10.202513:16 Diagnosis of multiple sclerosis 2024 revisions of the McDonald criteria The Lancet Neurology
מן הרשת 21.10.202513:15 Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Neurology
מן הרשת 21.10.202513:13 Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis Objective: To compare immunosuppressive treatments used in relapse prevention in NMO-SD Journal of Neurology
מן הרשת 21.10.202513:12 Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder To characterize the frequency and clinicoradiologic phenotype of cerebellar involvement in attacks of aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) which are incompletely captured in current diagnostic criteria Neurol Neuroimmunol Neuroinflamm.
מן הרשת 04.08.202514:39 Differential diagnosis of suspected multiple sclerosis: global health considerations The differential diagnosis of multiple sclerosis can present specific challenges in patients from Latin America, Africa, the Middle East, eastern Europe, southeast Asia, and the Western Pacific Lancet Neurol
מן הרשת 04.08.202514:37 De-escalating and discontinuing disease-modifying therapies in multiple sclerosis the question of when and how to de-escalate or discontinue DMTs remains open and critical Brain
מן הרשת 04.08.202514:35 Imaging chronic active lesions in multiple sclerosis: a consensus statement In recent years, the discovery of innovative MRI and PET-derived biomarkers has made it possible to detect CAL, and to some extent quantify them, in the brain of persons with multiple sclerosis, in vivo Brain
מן הרשת 04.08.202514:34 Neurodegeneration and demyelination in multiple sclerosis this review, we discuss the immune-glia interactions that underlie demyelination, failed remyelination, and neurodegeneration with a focus on PMS Neuron
מן הרשת 04.08.202514:32 Advancing multiple sclerosis management in older adults In this Consensus statement, we present the outcomes of an International Advisory Committee on Clinical Trials (IACCT) in MS workshop on ageing and MS; we review the current status of the field and identify knowledge gaps, and provide recommendations to advance the areas of unmet need Nature Reviews Neurology
מן הרשת 06.03.202513:05 Non-inferiority design for trials in multiple sclerosis When effective treatments exist, trials compare new drugs with those standards using either a superiority or non-inferiority design The Lancet Neurology
מן הרשת 06.03.202513:04 Advanced neuroimaging techniques to explore the effects of motor and cognitive rehabilitation in multiple sclerosis Progress in magnetic resonance imaging (MRI) technology and analyses is improving our comprehension of multiple sclerosis (MS) pathophysiology Journal of Neurology
מן הרשת 06.03.202513:01 Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis We aimed to explore the feasibility of a single, unified set of diagnostic criteria when applied to patients with suspected PPMS Annals of Neurology